 Antiviral Agents
"Antiviral Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
| Descriptor ID |
D000998
|
| MeSH Number(s) |
D27.505.954.122.388
|
| Concept/Terms |
Antiviral Agents- Antiviral Agents
- Agents, Antiviral
- Antivirals
- Antiviral Drugs
- Drugs, Antiviral
|
Below are MeSH descriptors whose meaning is more general than "Antiviral Agents".
Below are MeSH descriptors whose meaning is more specific than "Antiviral Agents".
This graph shows the total number of publications written about "Antiviral Agents" by people in this website by year, and whether "Antiviral Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 | | 2004 | 2 | 1 | 3 | | 2005 | 1 | 1 | 2 | | 2006 | 1 | 0 | 1 | | 2007 | 1 | 0 | 1 | | 2011 | 0 | 1 | 1 | | 2015 | 2 | 0 | 2 | | 2017 | 3 | 1 | 4 | | 2018 | 1 | 1 | 2 | | 2020 | 0 | 3 | 3 | | 2021 | 0 | 1 | 1 | | 2023 | 1 | 1 | 2 | | 2024 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Antiviral Agents" by people in Profiles.
-
Frutos AM, Ahmad HM, Ujamaa D, O'Halloran AC, Englund JA, Klein EJ, Zerr DM, Crossland M, Staten H, Boom JA, Sahni LC, Halasa NB, Stewart LS, Hamdan O, Stopczynski T, Schaffner W, Talbot HK, Michaels MG, Williams JV, Sutton M, Hendrick MA, Staat MA, Schlaudecker EP, Tesini BL, Felsen CB, Weinberg GA, Szilagyi PG, Anderson BJ, Rowlands JV, Khalifa M, Martinez M, Selvarangan R, Schuster JE, Lynfield R, McMahon M, Kim S, Nunez VT, Ryan PA, Monroe ML, Wang YF, Openo KP, Meek J, Yousey-Hindes K, Alden NB, Armistead I, Rao S, Chai SJ, Kirley PD, Toepfer AP, Dawood FS, Moline HL, Uyeki TM, Ellington S, Garg S, Bozio CH, Olson SM. Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications - United States, 2023-2024. MMWR Morb Mortal Wkly Rep. 2024 Nov 14; 73(45):1022-1029.
-
Recommendations for Prevention and Control of Influenza in Children, 2024-2025: Technical Report. Pediatrics. 2024 Oct 01; 154(4).
-
Recommendations for Prevention and Control of Influenza in Children, 2024-2025: Policy Statement. Pediatrics. 2024 Oct 01; 154(4).
-
Caserta MT, O'Leary ST, Munoz FM, Ralston SL. Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection. Pediatrics. 2023 Jul 01; 152(1).
-
Antoon JW, Hall M, Feinstein JA, Kyler KE, Shah SS, Girdwood ST, Goldman JL, Grijalva CG, Williams DJ. Guideline-Concordant Antiviral Treatment in Children at High Risk for Influenza Complications. Clin Infect Dis. 2023 02 08; 76(3):e1040-e1046.
-
Hamdan L, Probst V, Haddadin Z, Rahman H, Spieker AJ, Vandekar S, Stewart LS, Williams JV, Boom JA, Munoz F, Englund JA, Selvarangan R, Staat MA, Weinberg GA, Azimi PH, Klein EJ, McNeal M, Sahni LC, Singer MN, Szilagyi PG, Harrison CJ, Patel M, Campbell AP, Halasa NB. Influenza clinical testing and oseltamivir treatment in hospitalized children with acute respiratory illness, 2015-2016. Influenza Other Respir Viruses. 2022 03; 16(2):289-297.
-
House SA, Shubkin CD, Lahey T, Brosco JP, Lantos J. COVID-19 Trial Enrollment for Those Who Cannot Consent: Ethical Challenges Posed by a Pandemic. Pediatrics. 2020 11; 146(5).
-
Casto AM, Stout SC, Selvarangan R, Freeman AF, Newell BD, Stahl ED, Ahmed AA, Greninger AL, Yin DE. Evaluation of Genotypic Antiviral Resistance Testing as an Alternative to Phenotypic Testing in a Patient with DOCK8 Deficiency and Severe HSV-1 Disease. J Infect Dis. 2020 06 11; 221(12):2035-2042.
-
Rhoden E, Ng TFF, Campagnoli R, Nix WA, Konopka-Anstadt J, Selvarangan R, Briesach L, Oberste MS, Weldon WC. Antifungal Triazole Posaconazole Targets an Early Stage of the Parechovirus A3 Life Cycle. Antimicrob Agents Chemother. 2020 02 21; 64(3).
-
McLaughlin M. Safe and effective medication utilization in pediatric patients requiring rehabilitation services during the Coronavirus pandemic of 2019. J Pediatr Rehabil Med. 2020; 13(3):221-223.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|